Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 135

1.

Predictors of loss to follow-up of tuberculosis cases under the DOTS programme in Namibia.

Kibuule D, Aiases P, Ruswa N, Rennie TW, Verbeeck RK, Godman B, Mubita M.

ERJ Open Res. 2020 Mar 16;6(1). pii: 00030-2019. doi: 10.1183/23120541.00030-2019. eCollection 2020 Jan.

2.

Clinical Significance of the Plasma Protein Binding of Rifampicin in the Treatment of Tuberculosis Patients.

Verbeeck RK, Singu BS, Kibuule D.

Clin Pharmacokinet. 2019 Dec;58(12):1511-1515. doi: 10.1007/s40262-019-00800-1. No abstract available.

PMID:
31332668
3.

Effectiveness of community-based DOTS strategy on tuberculosis treatment success rates in Namibia.

Kibuule D, Rennie TW, Ruswa N, Mavhunga F, Thomas A, Amutenya R, Law MR, Günther G, Ette E, Godman B, Verbeeck RK.

Int J Tuberc Lung Dis. 2019 Apr 1;23(4):441-449. doi: 10.5588/ijtld.17.0785.

PMID:
31064623
4.

Predictors of tuberculosis treatment success under the DOTS program in Namibia.

Kibuule D, Verbeeck RK, Nunurai R, Mavhunga F, Ene E, Godman B, Rennie TW.

Expert Rev Respir Med. 2018 Nov;12(11):979-987. doi: 10.1080/17476348.2018.1520637. Epub 2018 Oct 4.

PMID:
30198358
5.

Monitoring of gentamicin serum concentrations in obstetrics and gynaecology patients in Namibia.

Singu BS, Mubita M, Thikukutu MM, Mufenda JK, McKenzie SB, Verbeeck RK.

Int J Clin Pharm. 2018 Jun;40(3):520-525. doi: 10.1007/s11096-018-0626-8. Epub 2018 Mar 28.

PMID:
29594677
6.

Biowaiver Monographs for Immediate-Release Solid Oral Dosage Forms: Enalapril.

Verbeeck RK, Kanfer I, Löbenberg R, Abrahamsson B, Cristofoletti R, Groot DW, Langguth P, Polli JE, Parr A, Shah VP, Mehta M, Dressman JB.

J Pharm Sci. 2017 Aug;106(8):1933-1943. doi: 10.1016/j.xphs.2017.04.019. Epub 2017 Apr 21. Review.

PMID:
28435140
7.

Therapeutic Drug Monitoring in Tuberculosis: Practical Application for Physicians.

Alffenaar JC, Tiberi S, Verbeeck RK, Heysell SK, Grobusch MP.

Clin Infect Dis. 2017 Jan 1;64(1):104-105. Epub 2016 Oct 6. No abstract available.

8.

Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring.

Verbeeck RK, Günther G, Kibuule D, Hunter C, Rennie TW.

Eur J Clin Pharmacol. 2016 Aug;72(8):905-16. doi: 10.1007/s00228-016-2083-4. Epub 2016 Jun 15. Review.

PMID:
27305904
9.

The Lidose hard capsule formulation of fenofibrate is suprabioavailable compared to the nanoparticle tablet formulation under high-fat fed conditions.

Verbeeck RK, De Niet S, Lebrun S, Tremege M, Rennie TW, Coffiner M, Streel B, Cahay B.

J Pharm Pharm Sci. 2015;18(1):61-7.

10.

Prediction of paraquat exposure and toxicity in clinically ill poisoned patients: a model based approach.

Wunnapuk K, Mohammed F, Gawarammana I, Liu X, Verbeeck RK, Buckley NA, Roberts MS, Musuamba FT.

Br J Clin Pharmacol. 2014 Oct;78(4):855-66. doi: 10.1111/bcp.12389.

11.

Population pharmacokinetic analysis of tacrolimus early after pediatric liver transplantation.

Musuamba FT, Guy-Viterbo V, Reding R, Verbeeck RK, Wallemacq P.

Ther Drug Monit. 2014 Feb;36(1):54-61. doi: 10.1097/FTD.0b013e31829dcbcd.

PMID:
24081207
12.

Population pharmacokinetic analysis of tacrolimus in the first year after pediatric liver transplantation.

Guy-Viterbo V, Scohy A, Verbeeck RK, Reding R, Wallemacq P, Musuamba FT.

Eur J Clin Pharmacol. 2013 Aug;69(8):1533-42. doi: 10.1007/s00228-013-1501-0. Epub 2013 Apr 16.

PMID:
23588560
14.

Statistical tools for dose individualization of mycophenolic acid and tacrolimus co-administered during the first month after renal transplantation.

Musuamba FT, Mourad M, Haufroid V, De Meyer M, Capron A, Delattre IK, Verbeeck RK, Wallemacq P.

Br J Clin Pharmacol. 2013 May;75(5):1277-88. doi: 10.1111/bcp.12007.

15.

Population pharmacokinetics of four β-lactams in critically ill septic patients comedicated with amikacin.

Delattre IK, Musuamba FT, Jacqmin P, Taccone FS, Laterre PF, Verbeeck RK, Jacobs F, Wallemacq P.

Clin Biochem. 2012 Jul;45(10-11):780-6. doi: 10.1016/j.clinbiochem.2012.03.030. Epub 2012 Apr 5.

PMID:
22503878
16.

A simultaneous d-optimal designed study for population pharmacokinetic analyses of mycophenolic Acid and tacrolimus early after renal transplantation.

Musuamba FT, Mourad M, Haufroid V, Demeyer M, Capron A, Delattre IK, Delaruelle F, Wallemacq P, Verbeeck RK.

J Clin Pharmacol. 2012 Dec;52(12):1833-43. doi: 10.1177/0091270011423661. Epub 2011 Dec 29.

PMID:
22207766
17.

Application of dermal microdialysis for the determination of bioavailability of clobetasol propionate applied to the skin of human subjects.

Au WL, Skinner MF, Benfeldt E, Verbeeck RK, Kanfer I.

Skin Pharmacol Physiol. 2012;25(1):17-24. doi: 10.1159/000330489. Epub 2011 Aug 22.

PMID:
21860254
18.

Acenocoumarol sensitivity and pharmacokinetic characterization of CYP2C9 *5/*8,*8/*11,*9/*11 and VKORC1*2 in black African healthy Beninese subjects.

Allabi AC, Horsmans Y, Alvarez JC, Bigot A, Verbeeck RK, Yasar U, Gala JL.

Eur J Drug Metab Pharmacokinet. 2012 Jun;37(2):125-32. doi: 10.1007/s13318-011-0056-7. Epub 2011 Aug 3.

PMID:
21811894
19.

Population pharmacokinetic modeling and optimal sampling strategy for Bayesian estimation of amikacin exposure in critically ill septic patients.

Delattre IK, Musuamba FT, Nyberg J, Taccone FS, Laterre PF, Verbeeck RK, Jacobs F, Wallemacq PE.

Ther Drug Monit. 2010 Dec;32(6):749-56. doi: 10.1097/FTD.0b013e3181f675c2.

PMID:
20962708
20.

Comparative oral bioavailability of non-fixed and fixed combinations of artesunate and amodiaquine in healthy Indian male volunteers.

Fortin A, Verbeeck RK, Jansen FH.

Eur J Clin Pharmacol. 2011 Mar;67(3):267-75. doi: 10.1007/s00228-010-0911-5. Epub 2010 Oct 15.

PMID:
20949263
21.

Empirical models for dosage optimization of four beta-lactams in critically ill septic patients based on therapeutic drug monitoring of amikacin.

Delattre IK, Musuamba FT, Verbeeck RK, Dugernier T, Spapen H, Laterre PF, Wittebole X, Cumps J, Taccone FS, Vincent JL, Jacobs F, Wallemacq PE.

Clin Biochem. 2010 Apr;43(6):589-98. doi: 10.1016/j.clinbiochem.2009.12.007. Epub 2009 Dec 28.

PMID:
20036226
22.

Bioequivalence, therapeutic equivalence and generic drugs.

Verbeeck RK.

Acta Clin Belg. 2009 Sep-Oct;64(5):379-83. No abstract available.

PMID:
19999384
23.

Time of drug administration, CYP3A5 and ABCB1 genotypes, and analytical method influence tacrolimus pharmacokinetics: a population pharmacokinetic study.

Musuamba FT, Mourad M, Haufroid V, Delattre IK, Verbeeck RK, Wallemacq P.

Ther Drug Monit. 2009 Dec;31(6):734-42. doi: 10.1097/FTD.0b013e3181bf8623.

PMID:
19855314
24.

Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimus.

Musuamba FT, Rousseau A, Bosmans JL, Senessael JJ, Cumps J, Marquet P, Wallemacq P, Verbeeck RK.

Clin Pharmacokinet. 2009;48(11):745-58. doi: 10.2165/11318060-000000000-00000.

PMID:
19817503
25.

Pharmacokinetics and dosage adjustment in patients with renal dysfunction.

Verbeeck RK, Musuamba FT.

Eur J Clin Pharmacol. 2009 Aug;65(8):757-73. doi: 10.1007/s00228-009-0678-8. Epub 2009 Jun 20. Review.

PMID:
19543887
26.

Application of dermal microdialysis for the evaluation of bioequivalence of a ketoprofen topical gel.

Tettey-Amlalo RN, Kanfer I, Skinner MF, Benfeldt E, Verbeeck RK.

Eur J Pharm Sci. 2009 Feb 15;36(2-3):219-25. doi: 10.1016/j.ejps.2008.09.002. Epub 2008 Sep 20.

PMID:
18848881
27.

Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction.

Verbeeck RK.

Eur J Clin Pharmacol. 2008 Dec;64(12):1147-61. doi: 10.1007/s00228-008-0553-z. Epub 2008 Sep 2. Review.

PMID:
18762933
28.

The effect of ageing on cytochrome p450 enzymes: consequences for drug biotransformation in the elderly.

Wauthier V, Verbeeck RK, Calderon PB.

Curr Med Chem. 2007;14(7):745-57. Review.

PMID:
17346160
29.

Alfentanil-induced miosis as a surrogate measure of alfentanil pharmacokinetics in patients with mild and moderate liver cirrhosis.

Baririan N, Van Obbergh L, Desager JP, Verbeeck RK, Wallemacq P, Starkel P, Horsmans Y.

Clin Pharmacokinet. 2007;46(3):261-70.

PMID:
17328584
30.
31.

Ageing is associated with increased expression but decreased activity of CYP2E1 in male Wistar rats.

Wauthier V, Schenten V, Verbeeck RK, Calderon PB.

Life Sci. 2006 Oct 12;79(20):1913-20. Epub 2006 Aug 14.

PMID:
16904701
32.

Decreased CYP3A2 expression and activity in senescent male Wistar rats: is there a role for HNF4alpha?

Wauthier V, Verbeeck RK, Calderon PB.

Exp Gerontol. 2006 Sep;41(9):846-54. Epub 2006 Aug 7.

PMID:
16891075
33.

Generic substitution: the use of medicinal products containing different salts and implications for safety and efficacy.

Verbeeck RK, Kanfer I, Walker RB.

Eur J Pharm Sci. 2006 May;28(1-2):1-6. Epub 2006 Jan 18. Review.

PMID:
16413762
35.
36.

Fluconazole distribution in rat dermis following intravenous and topical application: a microdialysis study.

Mathy FX, Ntivunwa D, Verbeeck RK, Préat V.

J Pharm Sci. 2005 Apr;94(4):770-80.

PMID:
15729707
37.
38.
39.

In children, the addition of epinephrine modifies the pharmacokinetics of ropivacaine injected caudally.

Van Obbergh LJ, Roelants FA, Veyckemans F, Verbeeck RK.

Can J Anaesth. 2003 Jun-Jul;50(6):593-8.

PMID:
12826553
40.

Systemic delivery of parathyroid hormone (1-34) using inhalation dry powders in rats.

Codrons V, Vanderbist F, Verbeeck RK, Arras M, Lison D, Préat V, Vanbever R.

J Pharm Sci. 2003 May;92(5):938-50.

PMID:
12712413
41.

On-line determination of fluconazole in blood and dermal rat microdialysates by microbore high-performance liquid chromatography.

Mathy FX, Vroman B, Ntivunwa D, De Winne AJ, Verbeeck RK, Préat V.

J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Apr 25;787(2):323-31.

PMID:
12650755
42.

Cryopreservation of rat precision-cut liver slices is associated with major metabolic stress and ionic perturbations.

Vanhulle VP, Martiat GA, Bontemps F, Vincent MF, Pycke JM, Verbeeck RK, Horsmans Y, Delzenne N.

Cell Physiol Biochem. 2003;13(2):103-12.

PMID:
12649595
43.

In vivo tolerance assessment of skin after insertion of subcutaneous and cutaneous microdialysis probes in the rat.

Mathy FX, Denet AR, Vroman B, Clarys P, Barel A, Verbeeck RK, Préat V.

Skin Pharmacol Appl Skin Physiol. 2003 Jan-Feb;16(1):18-27.

PMID:
12566825
44.
45.

Role of taurine in osmoregulation during endurance exercise.

Cuisinier C, Michotte De Welle J, Verbeeck RK, Poortmans JR, Ward R, Sturbois X, Francaux M.

Eur J Appl Physiol. 2002 Oct;87(6):489-95. Epub 2002 Aug 10.

PMID:
12355187
46.

Validation of subcutaneous microdialysis sampling for pharmacokinetic studies of flurbiprofen in the rat.

Mathy FX, Preat V, Verbeeck RK.

J Pharm Sci. 2001 Nov;90(11):1897-906.

PMID:
11745747
47.
48.

Midazolam and cortisol metabolism before and after CYP3A induction in humans.

Eeckhoudt SL, Desager JP, Robert AR, Leclercq I, Verbeeck RK, Horsmans Y.

Int J Clin Pharmacol Ther. 2001 Jul;39(7):293-9.

PMID:
11471773
49.

[Interactions of food and drug metabolism].

Delzenne NM, Verbeeck RK.

J Pharm Belg. 2001 Mar-Apr;56(2):33-7. Review. French.

PMID:
11396348
50.

Comparative clinical pharmacokinetics of tacrolimus in paediatric and adult patients.

Wallemacq PE, Verbeeck RK.

Clin Pharmacokinet. 2001;40(4):283-95. Review.

PMID:
11368293

Supplemental Content

Loading ...
Support Center